18 completed, 8 terminated, 3 unknown, 2 recruiting. 31 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 31 | Completed 18, Terminated 8, Unknown 3, Recruiting 2 |
Follow Corticosteroids: new trials by email Literature Review of Corticosteroids trials Research Report on Corticosteroids
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Minimizing Glucocorticoid Administration in Patients With Proliferative Lupus Nephritis Rituximab, Mycophenolate Mofetil, Cyclophosphamide - Lupus Nephritis | Phase 4 | Recruiting | Institutul Clinic Fundeni | 30 | 2022-03-02 | 2022-03-03 |
| Top Down Versus Step up in Pediatric Ulcerative Colitis Infliximab, Corticosteroids - Ulcerative Colitis, Infliximab | Phase 4 | Recruiting | Children's Hospital of Fudan University | 40 | 2021-11-01 | 2024-02-28 |
| Belatacept With Early Steroid Withdrawal rATG and Everolimus in Renal Transplantation (BETTER Trial) Belatacept, Everolimus, mycophenolate mofetil - Kidney Transplant Rejection | Phase 4 | Unknown | University of Cincinnati | 120 | 2021-04-09 | 2021-04-19 |
| Steroid Sensitive Nephrotic Syndrome in Children Corticosteroids - Nephrotic Syndrome in Children | Phase 4 | Terminated | Wayne State University | 34 | 2019-08-06 | 2022-05-02 |
| Clinical Outcome of Delayed or Standard Prograf Together With Induction Therapy Followed by Conversion to Advagraf in Donation After Cardiac (or Circulatory) Death (DCD) Kidney Transplant Recipients Tacrolimus immediate-release formulation, Tacrolimus prolonged-release formulation, Induction therapy - Kidney Transplant | Phase 4 | Completed | Astellas Pharma China, Inc. | 284 | 2018-10-21 | 2024-10-31 |
| The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock Vitamin C, Hydrocortisone, Thiamine - Sepsis, Septic Shock | Phase 4 | Terminated | University Medical Centre Ljubljana | 5 | 2017-09-26 | 2019-02-19 |
| A Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal Impairment Lesinurad, XOI, Placebo - Gout, Chronic Kidney Disease (CKD) | Phase 4 | Terminated | Ironwood Pharmaceuticals, Inc. | 242 | 2017-07-19 | 2021-11-04 |
| Dosing Requirements of Astagraf XL® in African American Kidney Transplant Recipients Tacrolimus Extended Release Capsule, Mycophenolate mofetil, Prednisone - Immunosuppression | Phase 4 | Completed | Medical University of South Carolina | 25 | 2017-05-05 | 2019-12-26 |
| Additional Effects of Triamcinolone to Hyaluronic Acid on Knee Osteoarthritis Triamcinolone, Hyaluronic acid - Physical Activity, Functional Performance | Phase 4 | Unknown | Taipei Medical University | 56 | 2016-10-01 | 2016-11-01 |
| Corticosteroids With Vedolizumab in Crohn's Disease Prednisone, Placebo, Vedolizumab - Crohn's Disease | Phase 4 | Terminated | Icahn School of Medicine at Mount Sinai | 1 | 2016-04-01 | 2019-04-26 |
| Adjusted Steroids Therapy in Childerens With Idiopathic Nephrotic Syndrome Prednisone - Nephrotic Syndrome, Minimal Change | Phase 4 | Unknown | Rabin Medical Center | 75 | 2016-03-01 | 2016-01-12 |
| SCHEDULE Follow Up Visit 5-7 yr Everolimus, Cyclosporine, Mycophenolate mofetil - Heart Transplantation | Phase 4 | Completed | Novartis Pharmaceuticals | 95 | 2016-01-18 | 2019-10-03 |
| Sputum-derived Cellular Targets After Xolair (Omalizumab) Omalizumab, Placebo - Asthma | Phase 4 | Terminated | NYU Langone Health | 3 | 2016-01-01 | 2019-09-30 |
| Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM) Induction therapy, Corticosteroids, EVR+rCNI - End Stage Renal Disease (ESRD), Chronic Kidney Disease (CKD) | Phase 4 | Completed | Novartis Pharmaceuticals | 2037 | 2013-12-03 | 2019-01-30 |
| Efficacy of Everolimus in Combination With Tacrolimus in Liver Transplant Recipients Everolimus, Tacrolimus, Corticosteroids - Liver Transplantation | Phase 4 | Completed | Novartis Pharmaceuticals | 339 | 2012-05-24 | 2019-05-10 |
| A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus. Advagraf, Mycophenolate Mofetil, Sirolimus - Kidney Transplantation | Phase 4 | Completed | Astellas Pharma Inc | 853 | 2011-03-08 | 2024-10-31 |
| A Study Looking at Diabetes in Kidney Transplant Recipients Receiving Immunosuppressive Regimen With or Without Steroids Advagraf, Mycophenolate Mofetil, Simulect - Kidney Transplantation | Phase 4 | Completed | Astellas Pharma Inc | 1166 | 2011-01-22 | 2024-11-01 |
| Efficacy and Safety of Everolimus+EC-MPS After Early CNI Elimination vs EC-MPS +Tacrolimus in Renal Transplant Recipients Everolimus, Tacrolimus (FK506), Basiliximab - Chronic Renal Failure | Phase 4 | Completed | Novartis Pharmaceuticals | 36 | 2009-12-01 | 2014-08-15 |
| SCHEDULE - Scandinavian Heart Transplant Everolimus de Novo Study With Early Calcineurin Inhibitor (CNI) Avoidance Cyclosporine, Mycophenolate mofetil, Corticosteroids - Renal Function and Chronic Allograft Vasculopathy | Phase 4 | Completed | Novartis Pharmaceuticals | 115 | 2009-11-01 | 2015-06-10 |
| Study to Evaluate the Efficacy, Safety and Tolerability of Everolimus in de Novo Renal Transplant Recipients Participating in the Eurotransplant Senior Program Basiliximab, Enteric Coated Mycophenolic Acid (MPA), RAD001 - Renal Transplantation | Phase 4 | Terminated | Novartis Pharmaceuticals | 207 | 2009-07-01 | 2014-06-06 |
Showing 20 of 31. Sign in to see all of them.
Kidney Failure, Chronic (2) · Renal Insufficiency, Chronic (2) · Acute Kidney Injury (1) · Asthma (1) · Colitis, Ulcerative (1) · Critical Illness (1) · Crohn Disease (1) · Diabetes Mellitus (1) · Edema (1) · Gout (1) · Graft vs Host Disease (1) · Lupus Nephritis (1) · Motor Activity (1) · Nephrosis, Lipoid (1) · Nephrotic Syndrome (1)
Novartis Pharmaceuticals (9) · Astellas Pharma Inc (3) · Novartis (3) · Hoffmann-La Roche (2) · Astellas Pharma China, Inc. (1) · Children's Hospital of Fudan University (1) · Icahn School of Medicine at Mount Sinai (1) · Institutul Clinic Fundeni (1) · Ironwood Pharmaceuticals, Inc. (1) · Medical University of South Carolina (1) · NYU Langone Health (1) · Rabin Medical Center (1) · Taipei Medical University (1) · University Medical Centre Ljubljana (1) · University of Cincinnati (1)
Germany (9) · United States (9) · Norway (6) · Sweden (6) · Switzerland (6) · Czechia (5) · Poland (5) · Belgium (4) · China (4) · France (4) · Hungary (4) · Italy (4) · Netherlands (4) · Russia (4) · Spain (4)
Amit Dagan, Dr. (1) · Bruce E Sands, MD, MS (1) · Gener Ismail, MD, PhD (1) · James Fleming, PharmD (1) · Joan Reibman, MD (1) · Rita R Alloway, PharmD (1) · Ru-Lan Hsieh, MD (1)
PMID 21334736, PMID 22471345, PMID 25041227, PMID 25070687, PMID 25873064, PMID 26820618, PMID 27547871, PMID 28230646, PMID 29149958, PMID 29752413, PMID 29954336, PMID 30211826, PMID 30231851, PMID 30312541, PMID 30354362, PMID 31152476, PMID 31536556, PMID 32633157, PMID 34216395, PMID 34525259, PMID 34620664, PMID 34958762, PMID 36405821, PMID 40197799, PMID 42853965
2005 (1), 2008 (1), 2009 (1), 2016 (1)